initi coverag outperform pt other sought merger
partner enviabl posit abl move forward
uniqu domin market posit market blue brand afford
flexibl build pbm ingeniorx pursu partnership-bas
major player made move align better compet evolv
health care landscap evidenc merger cvs-aet ci-esrx howev
move ahead start ingeniorx launch
believ given domin posit blue brand
state oper market flexibl take time build pbm
expect much focu head center roll-out ingeniorx
expect gener annual run-rat cost save approxim
worth ep accru sharehold fulli transit
esrx expect end note time transit could prove
littl aggress compar past large-scal migrat regardless view
intern pbm import given view value-bas care
world manag pharmaci medic data enhanc done one roof
base convers pbm expert start pbm complic process
given numer compon need stand pbm fortun alreadi
necessari compon though need upgrad other
creat also abl reli number servic
near-term opportun govern busi medicar medicaid
beyond ingeniorx see growth antm govern busi return growth
commerci posit driver recent acquisit healthsun america choic
expand compani presenc market manag believ mid double-
digit organ membership growth achiev estim enrol growth
rang assum recent acquisit abl help reach
enrol target medicaid anoth area opportun number compani
singl note last quarter continu see pipelin billion
next year
establish ep estim respect
establish price target base five-year discount cash flow
analysi price target impli price-to-earnings multipl adjust ep project
suggest upsid current level note target multipl base
earn overst given benefit ingeniorx doesnt begin
assum benefit ingeniorx would impli target multipl closer
pleas see page report import disclosur
view compani recent commerci growth challeng less competit
pharmaci cost structur near-term issu solut come horizon
expect much focu head center roll-out pbm
ingeniorx compani expect ingeniorx gener annual run-rat cost save
approxim worth ep accru sharehold fulli
transit end time could prove littl aggress
believ build pbm strateg sound given market continu
move toward value-bas care beyond ingeniorx see growth antm govern
busi particularli posit driver particularli abl achiev
target mid double-digit organ membership growth
repres
commerci risk ex-hif
approxim flat y/i
faster expect
commerci risk ex-hif come
better expect
health benefit compani serv million medic member
decemb manag oper three segment commerci
specialti govern independ license cross
shield associ bcbsa associ independ health benefit plan offer
spectrum network-bas manag care plan larg small employ individu
medicaid senior market build pharmaci benefit manag
ingeniorx expect begin serv member begin januari
initi coverag outperform rate price target
view compani recent commerci growth challeng less competit
pharmaci cost structur near-term issu potenti solut
horizon expect much focu head center roll-out
ingeniorx compani expect ingeniorx gener annual run-rat cost
save approxim worth ep accru sharehold
membership fulli transit esrx expect complet end
note time transit could prove littl aggress
look past large-scal migrat regardless howev believ build
pbm strateg sound given market continu move toward
value-bas care increasingli make sens combin pharmaci
medic benefit one roof
market shift toward greater care coordin value-bas care
wit major player market move align
evolv health care landscap alreadi see number model emerg includ
unh/hum provider-own model cvs-aet retail-own model
ci-esrx model base partnership rather own model
provid creat align network instead find merger partner
move ahead start ingeniorx launch
believ given domin posit blue brand
state oper market flexibl take time build-out
pbm
ingeniorx follow strateg rational combin medic pharmaci
believ effect care coordin enhanc combin pharmaci
medic data given pharmaci typic first-lin often prevent
treatment resort costli medic care compani
current merg togeth would claim manag pharmaci
medic data think abil enhanc one roof partnership
pbm health plan work repres domin way two
interact still differ incent underli relationship relationship
esrx perfect exampl partnership start well
becam problemat two side couldnt agre common path
note recent confer call host one expert discuss
formulari choic differ stand-alone part plan ma-pd plan note
part d-onli formulari design maxim rebat drive lowest drug spend
ma-pd formulari design minim net health care cost could
mean allow higher drug spend move toward value-bas care attempt
lower net health care cost would argu valu pbm increas
intern health plan note isnt necessarili lost
market given premium valuat afford part intern pbm
capabl optumrx
note earlier see three differ model among payer emerg includ
unh/hum provider-own model cvs-aet retail-own model
antms/ci-esrx model base partnership own model
provid creat align network market view
strategi acquir provid asset favor although note also partner
provid would agre well believ own provid allow
greater control ensur care deliv consist manner howev
dont believ that way deliv effect value-bas care
convers execut coupl largest not-for-profit health system
suggest properli align network payer provid deliv equal
health system execut share three key view believ import
development/evolut health care system own health plan
pbm provid strateg benefit one doesnt necessarili need own/employ
physician network long incent align health system
need limit provid care health plan member accord
execut physician necessarili need own health system
long health plan ensur partner high-qual physician
incentiv practic value-bas mindset think uniqu
posit take advantag dynam unlik peer
benefit gener domin player market
blue brand enabl extract better discount provid
dynam allow approach provid piec equat partnership
beyond ingeniorx see growth antm govern busi posit driver
recent acquisit healthsun america choic expand compani
presenc market compani rate profil member
plan star higher enabl gain share organ recent
earn call manag note view mid double-digit organ membership
growth achiev model enrol growth driven
acquisit estim enrol growth rang
assum recent acquisit abl help reach enrol target
medicaid anoth area opportun number compani singl
note last quarter continu see pipelin billion next
year recogn north carolina remain biggest prize note
find success current partnership bcb minnesota
expect go live serv medicaid dual-elig member
begin serv portion estim member
expect gain coverag virginia medicaid expans
qualit perspect believ potenti near-term implic
ingeniorx posit neg mostli understood appreci
investor standup/rollout ingeniorx drastic improv compani
pharmaci cost structur enabl better compet membership fulli
insur commerci space medicar advantag quantit appear
disagr compani expect bb annual run-rat save
membership fulli transit approxim ep base
share count accru sharehold howev wide rang
ep estim first year ingeniorx expect go live spread
high low estim greater next
widest spread among peer group accord review thomson estim
estim may incorpor save ingeniorx believ
spread reflect lack consensu model save ingeniorx
actual save quickli save realiz
expect hit run-rat save target membership fulli transit
ingeniorx/cv handl certain back offic function ingeniorx
five-year period expect complet end project
assum ratabl save ramp compani achiev goal mm run-
rate end sake simplic model save
reduct commerci risk estim time model
save mm improv commerci medic expens rel
unadjust project bp y/i improv rise ratabl dollar
basi mm bp y/i improv vs unadjust
project y/i improv shrink ratabl throughout year
anniversari save possibl save ramp faster expect
accord compani fulli insur membership renew
januari could repres sourc upsid project project
line manag guidanc abl transit
member end
base convers pbm expert start pbm complic process
given numer compon need stand pbm
difficult build scratch other fortun alreadi
necessari compon other creat
basic build block compris claim adjud system pharmaci
therapeut committe coverag manag team appeal
contract manag system account manag salesforc
figur compon provid pbm servic
cowen compani
accord expert fundament element pbm claim
adjud system process claim whether retail mail specialti
work tandem claim adjud system plan file well
elig manag system file consist plan design
upward thousand larg health plan notabl high-pow clinic staff
made pharmacist physician necessari serv clinic consciou
organ clinic staff work committe develop
formulari well coverag criteria rule prior author step
rule quantiti limit drug quantiti manag pharmaci
distribut system consist retail network mail servic offer specialti
pharmaci servic built beyond pbm implement system contract
manag financi report client report addit order attract
new client salesforc need well account manag team maintain
relat exist client lastli member commun strategi need
provid inform member regard chang updat benefit
ingeniorx goe live provid claim adjud pharmaci
distribut servic manag capabl
alreadi expert believ
augment current capabl build other scratch accord
expert alreadi clinic staff includ committe
commerci medicar busi allow develop
formulari howev like reli esrx certain servic probabl
includ monograph class review need supplement current
capabl also bolster coverag manag appeal
capabl beyond probabl deleg
capabl esrx certain extent salesforc capabl
expand specif sell pbm servic difficult member
commun also like easi given alreadi
medic side contract manag anoth capabl would easi
like alreadi fairli robust contract manag system place
creat account manag team hard compet team could
prove littl difficult due complex creat report system could
challeng lastli formulari administr like difficult capabl
due level specif clinic talent requir
addit complic may aris stand pbm ingeniorx
transit esrx may go smoothli quickli expect
evidenc previou large-scal pbm membership transit notabl migrat
esrx onto one platform follow acquisit mh took longer cost
initi expect note unh transit commerci busi back
mh roughli size antm busi esrx took
month complet roughli two year prepar beforehand antm
favor believ on-schedul transit fulli reflect share price
convers consult industri expert suggest
concern compani abil achiev target would expect market
forgiv issu time one sinc would expect even
exit
although near-term catalyst close monitor compani longer
term plan ingeniorx possibl antm membership fulli
transit ingeniorx could compet extern pbm membership well howev
opportun less certain imposs forecast even compani
gain extern live expect meaning near-term earn
one area watch rebound antm commerci busi manag
comment last quarter continu work strategi segment
increas focu sale execut appear manag understand mistak
made ahead reinstat hif precipit share loss
larg group fulli insur busi manag indic client look
plan flexibl seem unabl provid time partli
address issu begun build product modular way enabl
consist effect product deploy think materi rebound
commerci enrol could end signific earn driver estim
bp improv commerci enrol add roughli per share
littl ep
earn import quarter year manag care
compani complet claim inform accur assess
cost trend reserv level survey employ
expect medic pharmaci cost trend next year survey result
suggest employ expect cost trend rel stabl
posit manag care group howev note medic cost trend
mute past year uptick underli medic cost trend
may difficult predict product price within commerci medicar
believ compani larg commerci individual/smal group medicar
advantag book like biggest beneficiari hif-holiday
medicar advantag believ insur use hif-holiday improv margin
and/or enhanc benefit drive addit growth major individu
group medicar advantag enrol growth come annual enrol
period octob decemb januari effect date
compani expect mid-doubl digit growth medicar advantag vs industri
averag growth indic expect take share competitor small
compon total medicar advantag book expect continu grow
group medicar advantag membership admittedli small base
begin sens compani perform releas monthli
medicar advantag enrol report mid-januari februari note
complet two medicar advantag acquisit within last month
ad member
much focu around rebat center pharma suppli chain
compani pbm distributor fair note plan stand
pbm ingeniorx expect start action taken
trump administr could impact ingeniorx mid-juli hh sent
regul offic manag budget omb entitl remov
harbor protect rebat plan pbm involv prescript pharmaceut
creation new harbor protect market gener interpret
mean remov rebat medicar part eventu commerci market
well believ expect chang occur dont believ wholesal
chang current system like even major chang would
expect time year give compani time adjust
establish ep estim
respect establish price target base five-year
discount cash flow analysi price target impli price-to-earnings multipl
adjust ep project suggest upsid current level note
target multipl base earn overst given benefit
ingeniorx doesnt begin assum benefit ingeniorx would
impli target multipl closer
addit note ep estim consensu
note previous wide rang ep estim
spread high low estim estim toward lower end
rang extent abl transit membership schedul
would like repres upsid ep project
use five-year discount cash flow analysi primari valuat method
deriv price target assum discount rate may appli
appropri adjust depend compani and/or industri specif factor
termin growth rate believ discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run addit believ
impli equiti valu dcf could prove conserv excess cash calcul
cash less total debt contempl parent compani cash
conserv way calcul excess cash secondari measur look
forward price-to-earnings multipl impli dcf analysi compar histor
bear case risk call
medic cost trend mute past year uptick
underli medic cost may difficult predict product price within
commerci medicar market said believ insul given
histor blue aggress price would
impact except coupl market
transit ingeniorx could take longer expect addit amount
compani believ gain save could come current estim
could turn impact amount expect revert sharehold
possibl transit time exce month could result higher
cost and/or delay realiz full save benefit improv
note earlier potenti propos hh regard futur rebat could
impact would expect potenti impact
headlin risk vs meaning impact remain chanc administr could
propos sweep broad new guidelin
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
compani report cowen compani
expens expens ratio chang expens sg ex non-recur ratio ex non-recur tax add back hif-rel tax rate pre-tax hif-rel tax share o/ amort ep ex chang year-over-year premium sg ex non-recur ex non-recur end decemb cowen
million except per-shar data
compani report cowen compani
revenu premium expens expens ratio expens expens expens sg ex non-recur ratio ex non-recur oper tax add back hif-rel tax rate pre-tax hif-rel tax expens tax rate incom share o/ amort ep ex net incom chang year-over-year premium revenu cowen
million
cowen compani
assetscash cash term tax tax invest lend held current current assetsproperti equip intang term liabilitiesunpaid life accid polici policyhold accru tax trade pend portion long-term debt short-term lend held current current liabilitieslong-term debt benefits/reserv futur polici tax non-current equitycommon paid comprehens sharehold liabil sharehold liquid ratio current receiv claim payabl capit structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
oper activitiesnet gain net properti equip impair gain extinguish gain sale incom tax benefit share-bas loss discontinu oper asset polici liabilities/ medic unearn account payabl accru incom taxes- oper proce purchas secur asset proce repay debt acquisit /disposit netpurchas properti equip common stock dividend chang secur lend collater payabl net- begin net increas decreas end year end decemb cowen
compani report cowen compani
oper activitiesnet gain impair gain extinguish sale incom net tax benefit share-bas loss discontinu properti oper asset invest polici liabilities/ medic unearn account payabl accru incom net oper invest activitiespurchas fix matur proce fix matur matur call purchas equiti proce sale equiti purchas invest proce sale invest settlement non-hedg chang secur lend purchas subsidiari net cash acquired- proce sale subsidiari net cash sold- purchas properti proce sale properti net invest financ activitiesnet proce repay commerci proce long-term repay long-term proce short-term repay short-term chang secur lend chang bank premium paid equiti call proce sale put options- common stock proce issuanc common chang collater settlement debt-rel derivatives- dividend tax paid withhold common stock esp- excess tax benefit share-bas net financ net effect foreign begin net increas decreas end year end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
medicar market said believ insul given histor
blue aggress price would impact except
transit ingeniorx could take longer expect addit amount
compani believ gain save could come current estim
could turn impact amount expect revert sharehold
possibl transit time exce month could result higher cost
and/or delay realiz full save benefit improv pharmaci cost
